AAAAAA

   
Results: 1-19 |
Results: 19
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer
Authors: Rubin, BP Skarin, AT Pisick, E Rizk, M Salgia, R
Citation: Bp. Rubin et al., Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer, EUR J CAN P, 10(1), 2001, pp. 77-82
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
Authors: Herbst, RS Lynch, C Vasconcelles, M Teicher, BA Strauss, G Elias, A Anderson, I Zacarola, P Dang, NH Leong, T Salgia, R Skarin, AT
Citation: Rs. Herbst et al., Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial, CANC CHEMOT, 48(2), 2001, pp. 151-159
Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer
Authors: Salgia, R Harpole, D Herndon, JE Pisick, E Elias, A Skarin, AT
Citation: R. Salgia et al., Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer, ANTICANC R, 21(2B), 2001, pp. 1241-1246
SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL
Authors: Sattler, M Verma, S Pride, YB Salgia, R Rohrschneider, LR Griffin, JD
Citation: M. Sattler et al., SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL, J BIOL CHEM, 276(4), 2001, pp. 2451-2458
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
Authors: Wang, WL Healy, ME Sattler, M Verma, S Lin, J Maulik, G Stiles, CD Griffin, JD Johnson, BE Salgia, R
Citation: Wl. Wang et al., Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571, ONCOGENE, 19(31), 2000, pp. 3521-3528
Unusual presentations of lung cancer - Case 1. Small bowel obstruction dueto metastatic lung cancer
Authors: Galsky, M Darling, M Hecht, J Salgia, R
Citation: M. Galsky et al., Unusual presentations of lung cancer - Case 1. Small bowel obstruction dueto metastatic lung cancer, J CL ONCOL, 18(1), 2000, pp. 227-228
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
Authors: Sattler, M Verma, S Shrikhande, G Byrne, CH Pride, YB Winkler, T Greenfield, EA Salgia, R Griffin, JD
Citation: M. Sattler et al., The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells, J BIOL CHEM, 275(32), 2000, pp. 24273-24278
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo
Authors: Shen, Y Lyons, P Cooley, M Davidson, D Veillette, A Salgia, R Griffin, JD Schaller, MD
Citation: Y. Shen et al., The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo, J BIOL CHEM, 275(2), 2000, pp. 1405-1413
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase viathe epidermal growth factor receptor in ovarian cancer cells
Authors: Venkatakrishnan, G Salgia, R Groopman, JE
Citation: G. Venkatakrishnan et al., Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase viathe epidermal growth factor receptor in ovarian cancer cells, J BIOL CHEM, 275(10), 2000, pp. 6868-6875
BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration
Authors: Aguiar, RCT Yakushijin, Y Kharbanda, S Salgia, R Fletcher, JA Shipp, MA
Citation: Rct. Aguiar et al., BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration, BLOOD, 96(13), 2000, pp. 4328-4334
Molecular and cellular biological abnormalities in lung cancer and the potential for novel therapeutics
Authors: Salgia, R Skarin, AT
Citation: R. Salgia et At. Skarin, Molecular and cellular biological abnormalities in lung cancer and the potential for novel therapeutics, LUNG BIOL H, 140, 2000, pp. 3-25
Involvement of the adapter protein CRKL in integrin-mediated adhesion
Authors: Uemura, N Salgia, R Ewaniuk, DS Little, MT Griffin, JD
Citation: N. Uemura et al., Involvement of the adapter protein CRKL in integrin-mediated adhesion, ONCOGENE, 18(22), 1999, pp. 3343-3353
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility
Authors: Salgia, R Li, JL Ewaniuk, DS Wang, YB Sattler, M Chen, WC Richards, W Pisick, E Shapiro, GI Rollins, BJ Chen, LB Griffin, JD Sugarbaker, DJ
Citation: R. Salgia et al., Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility, ONCOGENE, 18(1), 1999, pp. 67-77
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin
Authors: Thomas, JW Cooley, MA Broome, JM Salgia, R Griffin, JD Lombardo, CR Schaller, MD
Citation: Jw. Thomas et al., The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin, J BIOL CHEM, 274(51), 1999, pp. 36684-36692
Molecular cloning and characterization of human trabeculin-alpha a giant protein defining a new family of actin-binding proteins
Authors: Sun, YP Zhang, JY Kraeft, SK Auclair, D Chang, MS Liu, Y Sutherland, R Salgia, R Griffin, JD Ferland, LH Chen, LB
Citation: Yp. Sun et al., Molecular cloning and characterization of human trabeculin-alpha a giant protein defining a new family of actin-binding proteins, J BIOL CHEM, 274(47), 1999, pp. 33522-33530
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1 alpha
Authors: Salgia, R Quackenbush, E Lin, J Souchkova, N Sattler, M Ewaniuk, DS Klucher, KM Daley, GQ Kraeft, SK Sackstein, R Alyea, EP von Andrian, UH Chen, LB Gutierrez-Ramos, JC Pendergast, AM Griffin, JD
Citation: R. Salgia et al., The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1 alpha, BLOOD, 94(12), 1999, pp. 4233-4246
Hematopoietic growth factors signal through the formation of reactive oxygen species
Authors: Sattler, M Winkler, T Verma, S Byrne, CH Shrikhande, G Salgia, R Griffin, JD
Citation: M. Sattler et al., Hematopoietic growth factors signal through the formation of reactive oxygen species, BLOOD, 93(9), 1999, pp. 2928-2935
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion
Authors: Li, J Nishizawa, K An, WQ Hussey, RE Lialios, FE Salgia, R Sunder-Plassmann, R Reinherz, EL
Citation: J. Li et al., A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion, EMBO J, 17(24), 1998, pp. 7320-7336
Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma
Authors: Salgia, R Hedges, TR Rizk, M Reimer, RH Skarin, AT
Citation: R. Salgia et al., Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma, LUNG CANC, 22(2), 1998, pp. 149-152
Risultati: 1-19 |